Andy Plump, architect of Takeda’s R&D overhaul, to retire next year

Andy Plump to step down as Takeda's R&D chief

Andy Plump, credited with a soup-to-nuts overhaul of Takeda's R&D in more than a decade of leadership at the division, has announced his retirement.

Andy Plump, architect of Takeda’s R&D overhaul, to retire next year

Plump joined Takeda during a turbulent period, pushed the company to work more closely with young biotechs and will leave it with what CEO Julie Kim called a “lasting foundation.”

Takeda's R&D chief Andy Plump to retire; Novo Nordisk appoints global research head

→ As Takeda celebrates a pair of FDA approvals, one of its top execs will be retiring in June 2027. Andy Plump joined Takeda from Sanofi in 2015, and has led R&D since December 2018 ...